Lewis B
Department of Chemical Pathology and Metabolic Disorders, United Medical School of St Thomas's Hospital, London.
J Clin Pathol. 1987 Sep;40(9):1118-27. doi: 10.1136/jcp.40.9.1118.
The relation between serum cholesterol concentrations and the incidence of coronary heart disease is continuous and curvilinear; there is neither epidemiological nor biological evidence to support the existence of a threshold value. There is a clinical need, however, for an acceptable definition of action limits and desirable ranges, based on the evidence that raised cholesterol concentrations are causally related to atherosclerotic heart disease. The European Atherosclerosis Society has proposed a set of cut off points, which, together with age and the presence of other risk factors, direct the clinician to an appropriate level of treatment. Because the changes of serum cholesterol during adult life appear unphysiological, these action limits do not require adjustment for age. The distribution of serum cholesterol in the United Kingdom population is such that a case finding strategy is required to identify the many persons at very high risk of coronary disease. Measurements of triglyceride, high density lipoprotein, apolipoproteins, and the investigation of hyperlipoproteinemia are informative but less mandatory.
血清胆固醇浓度与冠心病发病率之间的关系是连续且呈曲线的;没有流行病学或生物学证据支持阈值的存在。然而,基于胆固醇浓度升高与动脉粥样硬化性心脏病存在因果关系的证据,临床上需要对行动限值和理想范围给出可接受的定义。欧洲动脉粥样硬化协会提出了一组切点,结合年龄和其他危险因素的存在情况,指导临床医生确定适当的治疗水平。由于成年期血清胆固醇的变化似乎不符合生理规律,这些行动限值不需要根据年龄进行调整。英国人群血清胆固醇的分布情况表明,需要采用病例发现策略来识别众多冠心病高危人群。甘油三酯、高密度脂蛋白、载脂蛋白的检测以及高脂血症的调查虽有参考价值,但并非强制性要求。